A Study to Assess the Carriage of Pneumococci in Children Aged 1-5 Years, and Their Household Contacts
NCT02522546 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2019-03-22
Summary
Pneumococci are bacteria which can cause serious and potentially life threatening illnesses like meningitis and blood poisoning.
Pneumococcal vaccines (PCV) have been given in the national immunisation schedule since 2006.Carriage studies allow assessment of how the strains in the nose change over time, in that by clearing some strains away which other strains take up those niches in their place both in children and in their close/household contacts. This helps to inform the best use of the vaccines available and for future vaccine development and which strains would be useful to include.
Conditions
- Nasal Carriage of Pneumococci
Interventions
- OTHER
-
nasopharyngeal swab
nasopharyngeal swab
Sponsors & Collaborators
-
Public Health England
lead OTHER_GOV
Principal Investigators
-
Elizabeth Coates, PhD · Public Health England
Eligibility
- Min Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-07-31
- Primary Completion
- 2016-12-31
- Completion
- 2016-12-31
Countries
- United Kingdom
More Related Trials
-
PCV13 Impact on Pneumococcal Nasopharyngeal Carriage Study
NCT05114902 ·Status: UNKNOWN
-
PCV13 in Non-pregnant Papua New Guinean Women
NCT04183322 ·Status: COMPLETED
-
Streptococcus Pneumonia: Effects of PCV13 on Pneumococcal Carriage
NCT01109108 ·Status: COMPLETED
-
Protecting From Pneumococcus in Early Life (The PROPEL Trial)
NCT02628886 ·Status: UNKNOWN ·Phase: PHASE3
-
Carriage to Assess Protection of New Pneumococcal Vaccines - PCV15
NCT06731374 ·Status: RECRUITING ·Phase: PHASE4
-
Evaluating Vaccine Responses in Healthy Infants Receiving Their Routine Primary Immunisation According to the Accelerated United Kingdom Schedule at 2, 3 and 4 Months
NCT01425372 ·Status: COMPLETED
-
Effects of Pneumococcal Vaccine on Nasopharyngeal Carriage
NCT01925222 ·Status: COMPLETED
-
PCV7 in the Prevention of Nasopharyngeal Carriage of Vaccine Serotype (VT) Streptococcus Pneumoniae
NCT02133469 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity of 10-valent and 13-valent Pneumococcal Conjugate Vaccines in Papua New Guinean Children
NCT01619462 ·Status: UNKNOWN ·Phase: PHASE3
-
An Evaluation of PCV13 Vaccine Schedules, Comparing Impact of 2+1 vs 3+0 on Pneumococcal Carriage in Blantyre, Malawi
NCT04078997 ·Status: COMPLETED
-
Pneumococcal Vaccination of Fiji Infants
NCT00170612 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity Study of a 13-valent Pneumococcal Polysaccharide Conjugate Vaccine
NCT05092386 ·Status: COMPLETED ·Phase: PHASE1
-
Nasopharyngeal Carriage Study in Healthy Kenyan Toddlers
NCT02146365 ·Status: COMPLETED
-
Paediatric Post Pneumococcal Conjugate Vaccine Nasopharyngeal Carriage Study
NCT04401488 ·Status: UNKNOWN
-
PREVENTING PNEUMOcoccal Disease Through Vaccination (Study 2)
NCT04974294 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Subjects
NCT01531322 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating Safety of 13-Valent Pneumococcal Conjugate Vaccine in Healthy Elderly Subjects
NCT00500266 ·Status: COMPLETED ·Phase: PHASE3
-
Pneumonia Research and Vaccine Impact League
NCT03900520 ·Status: COMPLETED
-
A Phase 1b Clinical Trial of 13-valent Pneumococcal Polysaccharide Conjugate Vaccine
NCT06183216 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety and Immunogenicity of an Investigational Pneumococcal Vaccine in the Elderly Population
NCT00327665 ·Status: COMPLETED ·Phase: PHASE1
-
Nasopharyngeal Carriage of S. Pneumoniae
NCT04460313 ·Status: RECRUITING ·Phase: NA
-
Phase Ⅱ Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine
NCT07035054 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study of Pneumococcal 13-valent Conjugate Vaccine in Healthy People Aged 2 Months and Older
NCT02544698 ·Status: UNKNOWN ·Phase: PHASE1
-
Clinical Trial of PCV24 in Infants Aged 2-23 Months
NCT06800261 ·Status: RECRUITING ·Phase: PHASE1
-
Study Evaluating The Safety, Tolerability And Immunogenicity Of A 13-Valent Pneumococcal Conjugate Vaccine (13vPnC)
NCT00546572 ·Status: COMPLETED ·Phase: PHASE3